Intranasal drug delivery for brain targeting.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Current Drug Delivery

• Publication date

  2005-03-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1567201053586047PMID 16305417
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• A critical comparative insight on nanocarrier-based intranasal delivery of statins for neuroprotective applications.

  2026cites this paper
• Breaking the Barrier of Brain Disease Therapeutics: Advocating Targeted Drug Delivery for Improved Neuro-Resident Interventions.

  2026cites this paper
• Nose to Brain Delivery of Curcumin Loaded Therapeutic Nanostructures for Neurodegenerative Diseases.

  2026cites this paper
• Targeted intranasal brain delivery of brilliant blue G via mucoadhesive spanlastic nanovesicles attenuates neuroinflammation by limiting cGAS–STING signaling

  2026cites this paper
• Advancements in Nanotherapeutics for the Treatment of Depression via Intranasal Pathway: A Review

  2025cites this paper
• Chitosan-pectin complexes: a new frontier in biopolymer-based drug delivery systems.

  2025cites this paper
• Receptor-mediated nose-to-brain delivery of drug combination-loaded polymeric nanocarriers for the treatment of glioblastoma- current progress and future perspectives part II: polymeric nanocarriers for combination therapy and advanced targeting

  2025cites this paper
• Docetaxel and quercetin-loaded lipid nanocarrier optimized by quality by design for glioblastoma therapy: a ligand-conjugated and therapeutic repurposing approach

  2025influential citation
• Intranasal Delivery of Ligand-Conjugated NLCs Co-Loaded With Docetaxel and Quercetin: HPLC Method Development, Pharmacokinetics, and Brain Biodistribution in Wistar Rats for Glioblastoma.

  2025cites this paper
• A comparative study between two manufacturing processes for venlafaxine-loaded niosome (Nioven) production: optimization, characterization, pharmacokinetic investigations, depression management, and gene assessment

  2025cites this paper
• Modulation of antibody transport in the brain and spinal cord through the intranasal pathway

  2025cites this paper
• Rhamnosomes: A new generation of flexible vesicles for a boosted targeted nose-to-brain delivery of selegiline in the treatment of Parkinson's disease

  2024cites this paper
• Advancement in the nose-to-brain drug delivery of FDA-approved drugs for the better management of depression and psychiatric disorders.

  2024cites this paper
• Nose-to-Brain Targeted Delivery of Donepezil Hydrochloride via Novel Hyaluronic Acid-Doped Nanotransfersomes for Alzheimer's Disease Mitigation.

  2024cites this paper
• Nose to Brain: Exploring the Progress of Intranasal Delivery of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers

  2024cites this paper
• Nose to brain delivery of flurbiprofen from a solid lipid nanoparticles-based thermosensitive in-situ gel.

  2024cites this paper
• Navigating Central Oxytocin Transport: Known Realms and Uncharted Territories

  2024cites this paper
• To Explore Nasal-Brain Lymphatic System for Brain-Targeted Drug Delivery and to Treat Neurodegenerative Diseases.

  2024cites this paper
• A review on Advancements in Nanoparticles Based Pulmonary Drug Delivery

  2024cites this paper
• Intranasal therapies for neonatal hypoxic-ischemic encephalopathy: Systematic review, synthesis, and implications for global accessibility to care

  2024influential citation
• Advances in Aerosol Formulation for Targeted Delivery of Therapeutic Agents from Nose to Brain.

  2024cites this paper
• Mesenchymal stem cells as a promising therapy for alcohol use disorder.

  2024cites this paper
• DESIGN AND DEVELOPMENT OF INTRA NASAL IN SITU GEL - FORMING NANO STRUCTURED LIPID EMULSIONS OF CURCUMIN FOR BRAIN MALIGNANCIES

  2024cites this paper
• Age features of the correction of alcohol motivation and voluntary alcohol consumption by intranasal administration of dehydroepiandrosterone under long-term preventive alcoholization (experimental study)

  2023cites this paper
• Transnasal Aerosol Delivery via HFNC: A Question of Safety and Efficacy

  2023cites this paper
• Comparative pharmacodynamic study delineating the efficacy of amantadine loaded nano-emulsified organogel via intranasal versus transdermal route in rotenone-induced Parkinson's disease rat model

  2023cites this paper
• The prescription design and key properties of nasal gel for CNS drug delivery: A review.

  2023cites this paper
• The Application of Prodrugs as a Tool to Enhance the Properties of Nucleoside Reverse Transcriptase Inhibitors

  2023cites this paper
• An Overview of Current Progress and Challenges in Brain Cancer Therapy Using Advanced Nanoparticles.

  2023cites this paper
• Passive Targeted Drug Delivery of Venlafaxine HCl to the Brain by Modified Chitosan Nanoparticles: Characterization, Cellular Safety Assessment, and In Vivo Evaluation

  2023cites this paper
• Sniffing oxytocin: Nose to brain or nose to blood?

  2023influential citation
• Transferosome-Based Intranasal Drug Delivery Systems for the Management of Schizophrenia: a Futuristic Approach

  2023cites this paper
• Nanocarrier Mediated Intranasal Drug Delivery Systems for the Management of Parkinsonism: A Review.

  2023cites this paper
• Nanovesicular-Mediated Intranasal Drug Therapy for Neurodegenerative Disease

  2023cites this paper
• A Comprehensive Review on Nanomedicine: Promising approach for treatment of brain tumor through intranasal administration.

  2022cites this paper
• Brain targeted intra nasal acyclovir lipid nanoparticles; in-vitro characterization and in-vivo biodistribution studies.

  2022cites this paper
• Biodistribution analysis of an intranasal-delivered peptide by the nanoSPECT/CT imaging

  2022cites this paper
• Amelioration of oxidative stress utilizing nanoemulsion loaded with bromocriptine and glutathione for the management of Parkinson's disease.

  2022cites this paper
• Thin film hydration versus modified spraying technique to fabricate intranasal spanlastic nanovesicles for rasagiline mesylate brain delivery: Characterization, statistical optimization, and in vivo pharmacokinetic evaluation

  2022cites this paper
• Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date

  2022cites this paper
• Correction of the wake-sleep cycle by intranasal administration of dopamine in modeling of the preclinical stage of Parkinson's disease in rats

  2022cites this paper
• AN UPDATED REVIEW ON THE APPLICATION OF DENDRIMERS AS SUCCESSFUL NANOCARRIERS FOR BRAIN DELIVERY OF THERAPEUTIC MOIETIES

  2021cites this paper
• Nanostructured Lipid Carriers for Intranasal Administration of Olanzapine in the management of Schizophrenia.

  2021cites this paper
• Zolmitriptan Intranasal Spanlastics for Enhanced Migraine Treatment; Formulation Parameters Optimized via Quality by Design Approach

  2021cites this paper
• Innovative approach for nasal drug delivery system for brain target

  2021cites this paper
• Recent approaches and success of liposome-based nanodrug carriers for the treatment of brain tumor.

  2021cites this paper
• Strategies-Based Intrathecal Targeted Drug Delivery System for Effective Therapy, Modeling, and Controlled Release Action

  2021cites this paper
• Evaluation of Ribavirin–Poloxamer Microparticles for Improved Intranasal Absorption

  2021cites this paper
• Coconut oil-based resveratrol nanoemulsion: Optimization using response surface methodology, stability assessment and pharmacokinetic evaluation.

  2021cites this paper
• Polymers in Nasal Drug Delivery: An Overview

  2021cites this paper
• Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models.

  2021cites this paper
• Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders

  2021cites this paper
• Pharmacokinetic Characterisation and Comparison of Bioavailability of Intranasal Fentanyl, Transmucosal, and Intravenous Administration through a Three-Way Crossover Study in 24 Healthy Volunteers

  2021cites this paper
• Intranasal Drug Delivery: Novel Delivery Route for Management of Parkinson’s and Depression Neurological Disorders

  2021cites this paper
• Antipsychotic potential and safety profile of TPGS-based mucoadhesive aripiprazole nanoemulsion: Development and optimization for nose-to-brain delivery.

  2021cites this paper
• Brain targeting of venlafaxine HCl as a hydrophilic agent prepared through green lipid nanotechnology

  2021cites this paper
• In Vitro Comparative Study of Solid Lipid and PLGA Nanoparticles Designed to Facilitate Nose-to-Brain Delivery of Insulin

  2021cites this paper
• Intranasal gene therapy for the treatment of neurological disorders

  2021cites this paper
• A Physiologically Based Pharmacokinetic Model for Predicting Diazepam Pharmacokinetics after Intravenous, Oral, Intranasal, and Rectal Applications

  2021cites this paper
• Bioengineered Biomimetic and Bioinspired Noninvasive Drug Delivery Systems

  2021cites this paper
• Gel-based delivery of neurotherapeutics via naso-brain pathways

  2021cites this paper
• Development of Imatinib Mesylate-Loaded Liposomes for Nose to Brain Delivery: In Vitro and In Vivo Evaluation

  2021cites this paper
• An overview of anatomical and physiological aspects of the nose and the brain

  2021cites this paper
• Using PCG-Arginine nanoparticle mediated intranasal delivery of dynorphin A (1–8) to improve neuroprotection in MCAO rats

  2021cites this paper
• Intranasal route: The green corridor for Alzheimer's disease therapeutics

  2021cites this paper
• Design and In Vitro Evaluation of Intranasal Diazepam for Treating Acute Repetitive Seizures: a Technical Note

  2020cites this paper
• A Short Review on the Intranasal Delivery of Diazepam for Treating Acute Repetitive Seizures

  2020cites this paper
• Nose to brain drug delivery - a promising strategy for active components from herbal medicine for treating cerebral ischemia reperfusion.

  2020cites this paper
• Targeting the brain: various approaches and science involved

  2020cites this paper
• Formulation and Characterization of Amisulpride Microemulsions for Brain Targeting via Intranasal Route-Pharmacodynamic Evaluation in Rat Model

  2020cites this paper
• Effects of route of administration on oxytocin-induced changes in regional cerebral blood flow in humans

  2020cites this paper
• Buspirone loaded solid lipid nanoparticles for amplification of nose to brain efficacy: Formulation development, optimization by Box-Behnken design, in-vitro characterization and in-vivo biological evaluation

  2020cites this paper
• DEVELOPMENT AND CHARACTERIZATION OF LORATADINE NANOSYSTEMS FOR INTRANASAL DELIVERY USING QUALITY BY DESIGN APPROACH

  2020cites this paper
• Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies

  2020cites this paper
• Nose-to-brain delivery of antipsychotics using nanotechnology: a review

  2020cites this paper
• Biodistribution and amyloid beta induced cell line toxicity study of intranasal Rivastigmine microemulsion enriched with Fish Oil and Butter oil

  2020cites this paper
• Enhancement in brain uptake of vitamin D3 nanoemulsion for treatment of cerebral ischemia: formulation, gamma scintigraphy and efficacy study in transient middle cerebral artery occlusion rat models

  2020cites this paper
• Intranasal Subunit Vaccination Strategies Employing Nanomaterials and Biomaterials.

  2020cites this paper
• Intranasal delivery of interferon-β-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: A promising simple, effective, non-invasive, and low-cost therapy.

  2020cites this paper
• Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders

  2020cites this paper
• The role of rapid onset fentanyl products in the management of breakthrough pain in cancer patients

  2019cites this paper
• Do direct nose-to-brain pathways underlie intranasal oxytocin-induced changes in regional cerebral blood flow in humans?

  2019cites this paper
• Sucrose stearate as a biosurfactant for development of rivastigmine containing nanostructured lipid carriers and assessment of its activity against dementia in C. elegans model

  2019cites this paper
• Recent Advances and Novel Approaches for Nose to Brain Drug Delivery for Treatment of Migraine

  2019cites this paper
• Inhalation Drug Therapy: Emerging Trends in Nasal and Pulmonary Drug Delivery

  2019cites this paper
• Smart thermosensitive chitosan hydrogel for nasal delivery of ibuprofen to treat neurological disorders

  2019cites this paper
• The Strategies of Nanomaterials for Traversing Blood-Brain Barrier

  2019cites this paper
• A Review: Nose to Brain Drug Delivery for Various CNS Disorders

  2019cites this paper
• Do direct nose-to-brain pathways underlie intranasal oxytocin-induced changes in regional cerebral blood flow in humans? Running title: Investigating the validity of the intranasal OT route in humans

  2019cites this paper
• Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery.

  2019cites this paper
• Intranasal Zotepine Nanosuspension: intended for improved brain distribution in rats

  2019cites this paper
• Molecular Modeling of the antagonist compound esketamine and its molecular docking study with non-competitive N-methyl-D-aspartate (NMDA) receptors NR1, NR2A, NR2B and NR2D

  2019cites this paper
• Nose‐to‐brain drug delivery: An update on clinical challenges and progress towards approval of anti‐Alzheimer drugs

  2018cites this paper
• Treatment of pain with intranasal fentanyl in pediatric patients in an acute care setting: a systematic review.

  2018cites this paper
• Effect of intranasal insulin on peripheral glucose profile in dexamethasone-induced insulin resistance in Wistar rats

  2018cites this paper
• Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay

  2018cites this paper
• Estudo exploratório da administração intranasal do monoterpeno álcool perílico em pacientes com glioma recidivante

  2018cites this paper
• Brain targeted delivery of mucoadhesive thermosensitive nasal gel of selegiline hydrochloride for treatment of Parkinson's disease

  2018cites this paper
• Mechanism of intranasal drug delivery directly to the brain

  2018cites this paper
• Enhancing Antidepressant Effect of Poloxamer/Chitosan Thermosensitive Gel Containing Curcumin-Cyclodextrin Inclusion Complex

  2018cites this paper